Assessment of Cognitive Functions in Bipolar Patients

Assessment of Cognitive Functions in Bipolar Disorder Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04091828

Enrollment

Registered

2019-09-17

Start date

2019-10-31

Completion date

2022-11-30

Last updated

2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Brief summary

Assessment of cognitive function in manic bipolar patient

Detailed description

Assessment of severity of mania and depression in bipolar patients then evaluate their cognitive function.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Aged 18-55 years * Of both sex * Diagnosed as bipolar by DSM-5(patient)

Exclusion criteria

* Current medical and psychiatric comorbidities which may affect cognitive status. * Substance abuse or dependence (except nicotine and caffeine)in last month. * Somatic treatment with drugs known to affect cognitive status (cortisol, antihistamines, etc.)

Design outcomes

Primary

Measure	Time frame	Description
Assessment of severity of mania in bbipolar patients	2019-2022	EVALUATE manic patients by Young Mania Rating Scale (YMRS)
Assessment of severity of depression in bipoiar patients	2019-2022	Evaluate depressed patients by Hamilton Rating Scale for depression(HRS).
Assessment of cognitive function in bipoiar patients	2019-2022	Evaluate cognition in included patients by Montreal Cognitive Assessment(MOCA) and P300.

Secondary

Measure	Time frame	Description
Correlation between cognitive state in bipolar patient and(onset age,illness duration and number of episodes).	2019-2021	from history

Outcome results